Therefore, based on the current study findings, we hypothesize that the s-CSF2-Ab may directly contribute to the development of cancer by reducing p53 activity, and indirectly contribute to the onset of atherosclerosis-related AIS, AMI, and CKD through p53-mediated regulation of hypertension. The gene discussed is CSF2; the disease is chronic kidney disease.